Impact of Hepatitis B Immunoglobulins in Patients With Chronic Hepatitis B on Hepatocellular Carcinoma
Latest Information Update: 22 Mar 2024
At a glance
- Drugs Hepatitis B immune globulin (Primary)
- Indications Hepatitis B
- Focus Proof of concept; Therapeutic Use
- Acronyms HBIG-Pilot
Most Recent Events
- 22 Mar 2024 Status changed from not yet recruiting to discontinued, (global end of the trial-2024-02-08)
- 17 Jan 2024 Planned End Date changed from 1 Jun 2025 to 1 Jun 2026.
- 17 Jan 2024 Planned primary completion date changed from 1 Jun 2025 to 1 Jun 2026.